2007

Hellerbrand C, Bumes E, Bataille F, MassoumiR , Bosserhof fAK: Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28: 21 – 27 (2007)

Nickl-Jockschat T, Arslan F, Doerfelt A, Bogdahn U, Bosserhoff AK, and Hau P: A dysbalance between Smad and MAPK pathways is responsible for TGF-ß tumor promoting effects in high-grade gliomas. Int. J Oncol. 30: 499-507 (2007)

Rothhammer T, Bataille F, Spruss T, Eissner G, Bosserhoff AK: Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26:4158-4170 (2007)

Denk AE, Bettstetter M, Wild PJ, Bataille F, Dietmaier W, Bosserhoff AK: Loss of maspin expression contributes to a more invasive potential in malignant melanoma. PCR 20: 112 – 119 (2007)

Arndt S, Poser I, Moser M and Bosserhoff AK: Fussel-15, a novel ski/sno homolog protein, antagonizes BMP signaling. MCN 34: 603 – 611 (2007)

Raja C, Graham P, Rizvi S, Song E, Goldsmith H, Butler P, Thompson J, Bosserhoff A; Morgenstern A, Apostolidis C, Kearsley J, Reisfeld R, Allen BJ: Interim analysis of  toxicity and response in a Phase 1 trial of systemic targeted alpha therapy for metastatic melanoma.  Cancer Biology & Therapy (in press)

Hirner S, Müller J, Gullotti L, Günther T, Jacob A, Bosserhoff A, Schorle H, Schüle R and Buettner R: The LIM-only signal transducer FHL2 regulates myofibroblast contraction during wound healing. JCB 177: 163 – 172 (2007)

Arslan F, Bosserhoff AK, Nickl-Jockschat T, Doerfelt A, Bogdahn U, and Hau P: The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta 2. BJC 96:1560-1568 (2007)

Kasuno K, Naqvi A, Dericco J, Yamamori T, Santhanam L, Mattagajasingh I, Yang S, Meyskens FL, Bosserhoff AK, Irani K: Antagonism of p66shc by melanoma inhibitory activity. Cell Death Differ. 2007 (in press)

Wenke AK, Kjellmann C, Lundgren-Akerlund E, Uhlmann C, Haass NK, Herlyn M, Bosserhoff AK: Expression of integrin alpha10 is induced in malignant melanoma. Cell. Oncol. 29:373-286 (2007)

Rothhammer T, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hein R, Hofstaedter F, Bosserhoff AK: Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark. 3:111-117 (2007)

Stephanie Arndt, Anja K. Bosserhoff: Reduced expression of TANGO in colon and hepatocellular carcinomas. Oncol Rep 18:885-891 (2007)

Heimerl S, Bosserhoff AK, Langmann T, Ecker J, Schmitz G: Mapping ATP-Binding Cassette (Abc) Transporter Gene Expression Profiles In Melanocytes And Melanoma Cells. Mel. Res 17:265-273 (2007)

Kroll J, Becker KF, Kuphal S, Hein R, Hofstädter F and Bosserhoff AK: Isolation of high quality protein samples from punches of formalin fixed and paraffin embedded tissue blocks. Histology & Histopathology (in press)

Arndt S, Melle C, Mondal K, Klein G, von Eggeling F, Bosserhoff AK: Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes. J. Leukocyte Biol. (in press)

Hellerbrand C, Amann T, Schlegel J, Spruß T, Bataille F, Trautwein C, Bosserhoff AK: Melanoma inhibitory activity 2 (MIA2) is involved in hepatocellular carcinoma development and liver homoestasis. Gut (in press)

Kuphal S, Wallner S, Bosserhoff AK: Loss of POEM promotes tumor progression in malignant melanoma. Cancer Science (in press)